What You Need to Know About the Latest Breakthrough in Migraine Treatment
Migraine is a genetic neurological condition affecting 1 billion people worldwide. It is characterized by pulsating headaches lasting from a few hours to several days and be accompanied by nausea, vomiting and/or light/sound sensitivity.
Recently, a novel treatment for migraines has emerged in the form of a calcitonin gene-related peptide (CGRP) nasal spray. CGRP is a molecule that plays a key role in the development of migraine pain, and this nasal spray works by blocking CGRP from binding to its receptors in the brain. Clinical studies have shown that CGRP nasal spray can be an effective treatment for acute migraine attacks, providing relief as early as 15 minutes following administration. It also has a relatively low risk of side effects compared to other migraine medications, making it a promising option for patients who cannot tolerate other treatments or who want to avoid an oral option due to the nausea or vomiting associated with migraines.
While CGRP nasal spray is not a cure for migraines, it can significantly reduce the frequency and severity of attacks and improve the quality of life for those who suffer from this debilitating condition.
Written by Karamjeet Singh